# Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain

> **NCT03978234** · PHASE2 · UNKNOWN · sponsor: **University Foot and Ankle Foundation** · enrollment: 30 (estimated)

## Conditions studied

- Plantar Fasciitis
- Plantar Fasciitis, Chronic
- Plantar Fasciitis of Both Feet

## Interventions

- **DRUG:** AbobotulinumtoxinA 300 UNT

## Key facts

- **NCT ID:** NCT03978234
- **Lead sponsor:** University Foot and Ankle Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-20
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03978234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03978234, "Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03978234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*